A biochemical profile consistent with iron deficiency (low ferritin and transferrin saturation) occurred more frequently during follow‐up in patients randomized to dapagliflozin, consistent with an increased iron demand due to stimulation of erythropoiesis by SGLT2 inhibitors.5 The gene discussed is TF; the disease is nutritional disorder.